Process View
The process in which a relatively unspecialized cell acquires specialized features of a myoblast. A myoblast is a mononucleate cell type that, by fusion with other myoblasts, gives rise to the myotubes that eventually develop into striated muscle fibers.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "myoblast differentiation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SRF | serum response factor (c-fos serum response element-binding transcription factor) | 1.000 | ||
| RB1 | retinoblastoma 1 | 0.976 | ||
| NOTCH1 | notch 1 | 0.970 | ||
| TTN | titin | 0.950 | ||
| JAG1 | jagged 1 | 0.925 | ||
| E2F1 | E2F transcription factor 1 | 0.589 | ||
| HDAC4 | histone deacetylase 4 | 0.508 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.494 | Mouse | |
| JUN | jun proto-oncogene | 0.488 | ||
| NKX2-5 | NK2 transcription factor related, locus 5 (Drosophila) | 0.446 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.409 | ||
| ATF2 | activating transcription factor 2 | 0.358 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.308 | ||
| MYH7B | myosin, heavy chain 7B, cardiac muscle, beta | 0.264 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.241 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.237 | ||
| TCF4 | transcription factor 4 | 0.167 | ||
| CNOT8 | CCR4-NOT transcription complex, subunit 8 | 0.156 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.143 | Rat | |
| CREBBP | CREB binding protein | 0.133 | ||
| NOTCH3 | notch 3 | 0.131 | Human | |
| ATF3 | activating transcription factor 3 | 0.130 | ||
| INO80B | INO80 complex subunit B | 0.127 | ||
| FBLN1 | fibulin 1 | 0.121 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.119 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.106 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.103 | ||
| OBSL1 | obscurin-like 1 | 0.100 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.096 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.077 | ||
| PARVA | parvin, alpha | 0.062 | ||
| DLL1 | delta-like 1 (Drosophila) | 0.061 | ||
| MKL1 | megakaryoblastic leukemia (translocation) 1 | 0.061 | Human | |
| SMAD4 | SMAD family member 4 | 0.061 | ||
| RBL1 | retinoblastoma-like 1 (p107) | 0.061 | Human | |
| MYOCD | myocardin | 0.061 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.057 | ||
| HDAC9 | histone deacetylase 9 | 0.054 | ||
| CPNE6 | copine VI (neuronal) | 0.053 | ||
| AR | androgen receptor | 0.052 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.051 | Human Mouse | |
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.049 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.048 | ||
| EP300 | E1A binding protein p300 | 0.046 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.045 | ||
| FSTL1 | follistatin-like 1 | 0.045 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.042 | ||
| PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0.042 | ||
| ARRB1 | arrestin, beta 1 | 0.039 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.036 | ||
| PTPRC | protein tyrosine phosphatase, receptor type, C | 0.036 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.036 | ||
| TMSB10 | thymosin beta 10 | 0.035 | ||
| TNKS2 | tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 | 0.035 | ||
| AHR | aryl hydrocarbon receptor | 0.035 | ||
| CDT1 | chromatin licensing and DNA replication factor 1 | 0.035 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.034 | ||
| MYOG | myogenin (myogenic factor 4) | 0.034 | Mouse | |
| JUND | jun D proto-oncogene | 0.034 | ||
| MAML1 | mastermind-like 1 (Drosophila) | 0.033 | Mouse | |
| EIF2C1 | eukaryotic translation initiation factor 2C, 1 | 0.032 | ||
| DBP | D site of albumin promoter (albumin D-box) binding protein | 0.032 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.032 | ||
| HNRNPH1 | heterogeneous nuclear ribonucleoprotein H1 (H) | 0.031 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.031 | ||
| ENG | endoglin | 0.031 | ||
| GATA4 | GATA binding protein 4 | 0.030 | ||
| SPEN | spen homolog, transcriptional regulator (Drosophila) | 0.030 | ||
| SMAD1 | SMAD family member 1 | 0.030 | ||
| E2F5 | E2F transcription factor 5, p130-binding | 0.029 | ||
| HIC1 | hypermethylated in cancer 1 | 0.028 | ||
| CELF1 | CUGBP, Elav-like family member 1 | 0.027 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.027 | ||
| GLIS2 | GLIS family zinc finger 2 | 0.026 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.026 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.026 | ||
| RBL2 | retinoblastoma-like 2 (p130) | 0.026 | Human | |
| NOTCH2 | notch 2 | 0.025 | Human | |
| E2F2 | E2F transcription factor 2 | 0.025 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.025 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.025 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.024 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.024 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.024 | ||
| PNRC1 | proline-rich nuclear receptor coactivator 1 | 0.024 | ||
| PSEN1 | presenilin 1 | 0.024 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.024 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.024 | ||
| MKL2 | MKL/myocardin-like 2 | 0.023 | Human | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.022 | Human | |
| APC | adenomatous polyposis coli | 0.022 | ||
| RNF7 | ring finger protein 7 | 0.022 | ||
| VEGFA | vascular endothelial growth factor A | 0.022 | ||
| NOV | nephroblastoma overexpressed gene | 0.022 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.022 | ||
| MEF2C | myocyte enhancer factor 2C | 0.022 | ||
| MYOD1 | myogenic differentiation 1 | 0.021 | Mouse | |
| CUX1 | cut-like homeobox 1 | 0.021 | ||
| SMAD9 | SMAD family member 9 | 0.021 | ||
| APP | amyloid beta (A4) precursor protein | 0.020 | ||
| CCND1 | cyclin D1 | 0.020 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.020 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.020 | ||
| NOTCH2NL | notch 2 N-terminal like | 0.019 | ||
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.019 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.019 | ||
| PARVB | parvin, beta | 0.018 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.018 | ||
| E2F4 | E2F transcription factor 4, p107/p130-binding | 0.017 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.017 | ||
| TRIM43 | tripartite motif containing 43 | 0.017 | ||
| MCPH1 | microcephalin 1 | 0.016 | ||
| NCOA6 | nuclear receptor coactivator 6 | 0.016 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.016 | ||
| CNOT6L | CCR4-NOT transcription complex, subunit 6-like | 0.015 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.015 | ||
| INVS | inversin | 0.015 | ||
| JAG2 | jagged 2 | 0.015 | ||
| RUNX3 | runt-related transcription factor 3 | 0.015 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.014 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.014 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.013 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.013 | ||
| CCNG2 | cyclin G2 | 0.013 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.013 | ||
| ATXN1L | ataxin 1-like | 0.013 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.013 | ||
| TF | transferrin | 0.012 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.012 | Human | |
| ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.012 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.012 | ||
| RBM4B | RNA binding motif protein 4B | 0.012 | ||
| FOXF1 | forkhead box F1 | 0.012 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.012 | ||
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.012 | Human | |
| ASB13 | ankyrin repeat and SOCS box containing 13 | 0.012 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.012 | ||
| RBPMS | RNA binding protein with multiple splicing | 0.012 | ||
| TNRC6A | trinucleotide repeat containing 6A | 0.012 | ||
| HBP1 | HMG-box transcription factor 1 | 0.012 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.012 | ||
| CXCR3 | chemokine (C-X-C motif) receptor 3 | 0.012 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.011 | ||
| MAP2K7 | mitogen-activated protein kinase kinase 7 | 0.011 | ||
| ARRB2 | arrestin, beta 2 | 0.011 | ||
| DDX5 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 | 0.011 | ||
| FERMT2 | fermitin family member 2 | 0.011 | ||
| IFNG | interferon, gamma | 0.011 | ||
| ZEB2 | zinc finger E-box binding homeobox 2 | 0.011 | ||
| UBD | ubiquitin D | 0.011 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.011 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.011 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.011 | ||
| LEF1 | lymphoid enhancer-binding factor 1 | 0.011 | Human | |
| TAGLN | transgelin | 0.011 | ||
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | 0.011 | ||
| PURA | purine-rich element binding protein A | 0.011 | ||
| BTG1 | B-cell translocation gene 1, anti-proliferative | 0.011 | ||
| CCNE1 | cyclin E1 | 0.010 | ||
| EIF2C2 | eukaryotic translation initiation factor 2C, 2 | 0.010 | ||
| HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.010 |